CDK4/6i enhances the antitumor effect of PD1 antibody by promoting TLS formation in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDK4/6i enhances the antitumor effect of PD1 antibody by promoting TLS formation in ovarian cancer

Published:2023-09 Issue:9 Volume:9 Page:e19760
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Feng Wangyou^ORCID,Jiang Dongbo,Xu Ying,Li Yuanfeng,Chen Lin,Zhao Minye,Shen Yujie,Liao Wenjing,Yang Hong,Li Jia

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference50 articles.

1. Epithelial ovarian cancer;Lheureux;Lancet,2019

2. PD-L1 as a biomarker of response to immune-checkpoint inhibitors;Doroshow;Nat. Rev. Clin. Oncol.,2021

3. Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer;Hamanishi;J. Clin. Oncol.,2015

4. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer;Hamanishi;Proc. Natl. Acad. Sci. U.S.A.,2007

5. Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade;Cooper;Cancer Immunol. Res.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28

2. Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications;MedComm;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP